ducovest

HFXI:ARCA-IQ 50 Percent Hedged FTSE International (USD)

ETF | Foreign Large Blend | NYSE Arca

Last Closing

USD 27.4832

Change

+0.06 (+0.23)%

Market Cap

USD 0.17B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results that correspond generally to the price and yield performance of its underlying index, the FTSE Developed ex North America 50% Hedged to USD Index (the "underlying index"). The underlying index is an equity benchmark of international stocks from developed markets, with approximately half of the currency exposure of the securities included in the underlying index "hedged" against the U.S. dollar on a monthly basis. The fund invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the securities and other instruments included in its underlying index.

Company Website : www.indexiq.com

Currency: USD

Country : USA

Inception Date: 22/07/2015

Primary Benchmark: FTSE Dvlp ex NA 50% (US RIC) NR Hdg USD

Primary Index: MSCI ACWI Ex USA NR USD

Gross Expense Ratio: 0.36%

Management Expense Ratio: 0.20 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
ASML ASML Holding NV ADR 2.16 %
AZN AstraZeneca PLC ADR 1.25 %
SHEL Shell PLC ADR 1.22 %
SAP SAP SE ADR 1.19 %
ROG Rogers Corporation 1.06 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-16 )

Largest Industry Peers for Foreign Large Blend

Symbol Name Mer Price(Change) Market Cap
SCHF Schwab International Equity ET.. 0.06 %

-0.17 (-0.42%)

 USD 40.90B
SPDW SPDR S&P World ex US 0.05 %

-0.22 (-0.59%)

 USD 20.86B
IDEV iShares Core MSCI Internationa.. 0.03 %

-0.35 (-0.50%)

 USD 14.28B
IQLT iShares MSCI Intl Quality Fact.. 0.30 %

-0.13 (-0.32%)

 USD 8.37B
DBEF Xtrackers MSCI EAFE Hedged Equ.. 0.36 %

+0.04 (+0.10%)

 USD 6.35B
INTF iShares Edge MSCI Multifactor .. 0.30 %

-0.15 (-0.48%)

 USD 1.18B
QEFA SPDR® MSCI EAFE StrategicFact.. 0.30 %

-0.23 (-0.28%)

 USD 0.97B
JHMD John Hancock Multifactor Devel.. 0.45 %

-0.22 (-0.63%)

 USD 0.73B
MFDX PIMCO RAFI Dynamic Multi-Facto.. 0.40 %

-0.16 (-0.49%)

 USD 0.27B
HAWX iShares Currency Hedged MSCI A.. 0.03 %

-0.05 (-0.16%)

 USD 0.23B

ETFs Containing HFXI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Foreign Large Blend) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.51% 90% A- 66% D+
Dividend Return 1.47% 25% F 40% F
Total Return 11.98% 90% A- 64% D
Trailing 12 Months  
Capital Gain 13.45% 90% A- 67% D+
Dividend Return 1.96% 28% F 31% F
Total Return 15.41% 90% A- 64% D
Trailing 5 Years  
Capital Gain 34.92% 100% F 65% D
Dividend Return 12.33% 36% F 48% F
Total Return 47.25% 90% A- 65% D
Average Annual (5 Year Horizon)  
Capital Gain 7.06% 93% A 63% D
Dividend Return 9.24% 90% A- 62% D
Total Return 2.18% 34% F 48% F
Risk Return Profile  
Volatility (Standard Deviation) 15.01% 77% C+ 64% D
Risk Adjusted Return 61.55% 93% A 81% B-
Market Capitalization 0.17B 53% F 49% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.